Active	Status	Sponsor type	Region	Phase	Filter
6 Active 7 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kelly, John
iROC, NCT03049410: Trial to Compare Robotically Assisted Radical Cystectomy With Open Radical Cystectomy	Active, not recruiting	3	339	Europe	Intracorporeal Robot Assisted Radical Cystectomy, Open Radical Cystectomy	University College, London	Bladder Cancer	09/21	12/21
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD	Recruiting	3	568	Europe, Canada, US, RoW	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	03/25	05/25
NCT05481736: Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study	Completed	2	32	Europe, US	Psilocybin, COMP360	COMPASS Pathways	Anorexia Nervosa	11/24	11/24
HIVECII, NCT06768346: Hyperthermic Intra-Vesical Chemotherapy	Completed	N/A	259	Europe	Hyperthermia will be delivered in combination with each instillation using the Combat BRS system	Queen Mary University of London	Bladder Cancer	05/20	05/20
InTEGRA, NCT06395467: 12-Step Facilitation/MET/CBT () vs. MET/CBT for Youth With Alcohol and Other Drug Use Disorder	Not yet recruiting	N/A	294	US	InTEGRA, MET/CBT	Massachusetts General Hospital, National Institute on Alcohol Abuse and Alcoholism (NIAAA)	Alcohol Use Disorder, Cannabis Use Disorder	04/27	04/27
HALO-Trak, NCT05971277: Home And Locally Observed - Tracking	Recruiting	N/A	200	Europe	Halo Wearable data device	University College, London	Advanced Cancer	04/25	04/26